Management of obesity in patients with peripheral arterial disease.
Obesity is a major risk factor for cardiovascular disorders, including peripheral arterial disease. This review outlines the evidence for a 6-step process for the management of obesity, starting with identifying the degree and type of obesity, followed by target setting, life style and behavioural changes, imposed hypocaloric diet and physical activity, pharmacological treatment and consideration of eating disorders and/or bariatric surgery.
Giusti
V
V
Service of Endocrinology, Diabetology and Metabolism, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland.
D019440:Anti-Obesity Agents / Q000627:therapeutic use; D050110:Bariatric Surgery; D001823:Body Composition; D015992:Body Mass Index; D063387:Cannabinoid Receptor Antagonists; D002318:Cardiovascular Diseases / Q000453:epidemiology; D006801:Humans; D008019:Life Style; D009765:Obesity / Q000178:diet therapy / Q000453:epidemiology*; D016491:Peripheral Vascular Diseases / Q000453:epidemiology*; D010880:Piperidines / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D000077285:Rimonabant; D012307:Risk Factors; D014057:Tomography, X-Ray Computed
D019440:Anti-Obesity Agents; D063387:Cannabinoid Receptor Antagonists; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant